Contents

• Key Points
• Introduction
• Diagnostic considerations in young children
• Rationale for leukotriene antagonism in childhood asthma
• Clinical evidence for montelukast use in children
• Preventive treatment in children
• Other potential roles of LTRAs
• LTRA References
• Acknowledgements

PDF Version

 Leukotriene receptor antagonists: their therapeutic role in children with asthma 128.37 Kb

Published by National Asthma Council Australia Ltd.
ACN 058 044 634
Suite 104, Level 1
153-161 Park Street
South Melbourne VIC 3205
Australia
Tel: (+61) 3 9929 4333    Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Fax: (+61) 3 9929 4300    Website: http://www.nationalasthma.org.au/

Copyright
© 2007 National Asthma Council Australia Ltd

Disclaimer

Although all care has been taken, this information paper is a general guide only, which is not intended to be a substitute for individual medical advice/treatment. The National Asthma Council Australia expressly disclaims all responsibility (including for negligence) for any loss, damage or personal injury resulting from reliance on the information contained herein.

Suggested citation:

National Asthma Council Australia. Leukotriene receptor antagonists: their therapeutic role in children with asthma. Revised June 2007. Melbourne: National Asthma Council Australia, 2007.

Proudly supported by Merck Sharp & Dohme

This information paper was supported by an unrestricted educational grant from Merck Sharp & Dohme (Australia) Pty Ltd. National Asthma Council Australia retained editorial control.

Content Updated June 2007